Stock listing
BOATS:PYXS Pyxis Oncology, Inc. Stock
US listing (BOATS) of Pyxis Oncology, Inc. · home listing NASDAQ:PYXS
Follow Pyxis Oncology, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:PYXS
$1.69 USD -0.12 (-6.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PYXS
- Day range
- $1.63 – $1.86 USDNov 2, 2026
- Volume
- 897,144 sharesNov 2, 2026
- Market cap
- $201.9M USDAt the close on Nov 2, 2026 · price × 119.5M shares outstanding
- 52-week range
- $1.03 – $5.55 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $3.33M USDMedian day 730,300 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PYXS · Home | $1.69 USD | -0.12 (-6.6%) | 897,144 | $1.825 | $1.86 | $1.625 | $1.81 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:PYXS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.69 | -0.12 | -6.6% | $1.825 | $1.86 | $1.625 | 897,144 | |
| $1.81 | -0.08 | -4.2% | $1.88 | $1.88 | $1.78 | 685,656 | |
| $1.89 | -0.09 | -4.5% | $1.98 | $1.992 | $1.88 | 696,973 | |
| $1.98 | +0.14 | +7.6% | $1.83 | $1.99 | $1.80 | 728,050 | |
| $1.84 | +0.15 | +8.9% | $1.718 | $1.84 | $1.68 | 1,183,185 | |
| $1.69 | +0.01 | +0.6% | $1.66 | $1.72 | $1.634 | 645,782 | |
| $1.68 | -0.03 | -1.8% | $1.70 | $1.71 | $1.63 | 626,700 | |
| $1.71 | -0.05 | -2.8% | $1.74 | $1.79 | $1.695 | 557,500 | |
| $1.76 | -0.08 | -4.3% | $1.85 | $1.87 | $1.75 | 500,400 | |
| $1.84 | +0.08 | +4.5% | $1.76 | $1.90 | $1.73 | 1,110,300 | |
| $1.76 | +0.08 | +4.8% | $1.69 | $1.79 | $1.675 | 1,016,400 | |
| $1.68 | -0.12 | -6.7% | $1.79 | $1.79 | $1.66 | 908,200 | |
| $1.80 | +0.01 | +0.6% | $1.79 | $1.84 | $1.75 | 545,700 | |
| $1.79 | -0.06 | -3.2% | $1.82 | $1.88 | $1.735 | 1,558,200 | |
| $1.85 | -0.16 | -8.0% | $1.99 | $1.998 | $1.85 | 900,400 | |
| $2.01 | -0.02 | -1.0% | $2.03 | $2.08 | $1.99 | 505,700 | |
| $2.03 | +0.04 | +2.0% | $1.99 | $2.06 | $1.98 | 950,400 | |
| $1.99 | -0.02 | -1.0% | $2.03 | $2.03 | $1.902 | 1,097,100 | |
| $2.01 | -0.01 | -0.5% | $2.02 | $2.086 | $2.00 | 957,800 | |
| $2.02 | -0.22 | -9.8% | $2.22 | $2.22 | $2.00 | 1,403,400 | |
| $2.24 | +0.10 | +4.7% | $2.12 | $2.26 | $2.05 | 1,515,100 | |
| $2.14 | -0.05 | -2.3% | $2.21 | $2.31 | $2.10 | 1,996,600 | |
| $2.19 | -0.14 | -6.0% | $2.31 | $2.31 | $2.19 | 2,602,300 | |
| $2.33 | -0.57 | -19.7% | $2.375 | $2.41 | $2.12 | 8,149,500 | |
| $2.90 | 0.00 | 0.0% | $2.94 | $2.94 | $2.83 | 335,500 | |
| $2.90 | +0.04 | +1.4% | $2.81 | $2.91 | $2.75 | 368,100 | |
| $2.86 | -0.06 | -2.1% | $2.91 | $2.92 | $2.785 | 609,700 | |
| $2.92 | -0.30 | -9.3% | $3.22 | $3.25 | $2.86 | 875,300 | |
| $3.22 | -0.135 | -4.0% | $3.36 | $3.36 | $3.20 | 433,600 | |
| $3.355 | +0.165 | +5.2% | $3.21 | $3.405 | $3.19 | 479,800 | |
| $3.19 | -0.14 | -4.2% | $3.38 | $3.38 | $3.19 | 632,800 | |
| $3.33 | -0.08 | -2.3% | $3.38 | $3.44 | $3.33 | 563,900 | |
| $3.41 | +0.07 | +2.1% | $3.43 | $3.472 | $3.339 | 476,700 | |
| $3.34 | +0.01 | +0.3% | $3.34 | $3.42 | $3.32 | 639,900 | |
| $3.33 | -0.10 | -2.9% | $3.40 | $3.42 | $3.24 | 489,600 | |
| $3.43 | +0.22 | +6.9% | $3.21 | $3.515 | $3.21 | 699,500 | |
| $3.21 | -0.06 | -1.8% | $3.31 | $3.42 | $3.07 | 1,129,400 | |
| $3.27 | -0.11 | -3.3% | $3.42 | $3.437 | $3.18 | 738,500 | |
| $3.38 | -0.51 | -13.1% | $3.48 | $4.12 | $3.132 | 4,345,200 | |
| $3.89 | 0.00 | 0.0% | $4.00 | $4.15 | $3.845 | 1,375,600 | |
| $3.89 | +0.325 | +9.1% | $3.53 | $4.05 | $3.515 | 2,230,600 | |
| $3.565 | -0.185 | -4.9% | $3.71 | $3.74 | $3.45 | 812,100 | |
| $3.75 | +0.31 | +9.0% | $3.45 | $3.77 | $3.435 | 730,300 | |
| $3.44 | +0.20 | +6.2% | $3.24 | $3.57 | $3.18 | 590,200 | |
| $3.24 | +0.01 | +0.3% | $3.20 | $3.28 | $3.05 | 469,500 | |
| $3.23 | -0.09 | -2.7% | $3.32 | $3.38 | $3.20 | 212,000 | |
| $3.32 | -0.02 | -0.6% | $3.31 | $3.37 | $3.23 | 396,700 | |
| $3.34 | +0.28 | +9.2% | $3.03 | $3.36 | $3.00 | 634,200 | |
| $3.06 | +0.10 | +3.4% | $2.96 | $3.09 | $2.94 | 422,221 | |
| $2.96 | -0.12 | -3.9% | $3.02 | $3.07 | $2.825 | 837,591 | |
| $3.08 | -0.04 | -1.3% | $3.15 | $3.21 | $3.02 | 682,100 | |
| $3.12 | -0.25 | -7.4% | $3.30 | $3.39 | $3.03 | 716,100 | |
| $3.37 | +0.38 | +12.7% | $3.07 | $3.50 | $3.06 | 1,036,100 | |
| $2.99 | -0.03 | -1.0% | $3.03 | $3.13 | $2.97 | 353,400 | |
| $3.02 | +0.01 | +0.3% | $3.03 | $3.09 | $2.83 | 558,900 | |
| $3.01 | 0.00 | 0.0% | $2.99 | $3.08 | $2.862 | 703,800 | |
| $3.01 | -0.17 | -5.3% | $2.95 | $3.35 | $2.75 | 1,267,500 | |
| $3.18 | +0.35 | +12.4% | $2.76 | $3.211 | $2.72 | 1,935,600 | |
| $2.83 | -1.00 | -26.1% | $3.85 | $4.00 | $1.90 | 12,116,500 | |
| $3.83 | +0.10 | +2.7% | $3.72 | $3.985 | $3.72 | 999,100 | |
| $3.73 | -0.02 | -0.5% | $3.78 | $3.90 | $3.62 | 1,242,000 | |
| $3.75 | +0.62 | +19.8% | $3.14 | $3.77 | $3.13 | 1,395,500 | |
| $3.13 | -0.03 | -0.9% | $3.20 | $3.318 | $3.07 | 668,700 | |
| $3.16 | +0.12 | +3.9% | $3.02 | $3.25 | $3.02 | 926,100 | |
| $3.04 | +0.39 | +14.7% | $2.70 | $3.045 | $2.70 | 1,135,000 |
- Ticker
- BOATS:PYXS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Pyxis Oncology to Participate in Upcoming Investor Conferences
Latest deck · Sep 9, 2026
Corporate Update (September 2026)
Corporate update · 33 slides
Latest news
Pyxis Oncology to Participate in Upcoming Investor Conferences
Oct 28, 2026
Closed $1.98 (+7.6%) on Oct 28, 2026
Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Oct 27, 2026
Closed $1.84 (+8.9%) on Oct 27, 2026
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
Oct 2, 2026
Closed $2.14 (-2.3%) on Oct 2, 2026
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
Sep 30, 2026
Closed $2.33 (-19.7%) on Sep 30, 2026
Pyxis Oncology Announces Proposed Public Offering
Sep 29, 2026
Closed $2.33 (-19.7%) on Sep 30, 2026
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
Sep 9, 2026
Closed $3.38 (-13.1%) on Sep 9, 2026
Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board
Sep 8, 2026
Closed $3.89 (0.0%) on Sep 8, 2026
Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
Aug 13, 2026
Closed $3.01 (-5.3%) on Aug 13, 2026
Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones
Jun 30, 2026
Closed $3.01 (+5.2%) on Jun 30, 2026
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
May 7, 2026
Closed $2.74 (+21.2%) on May 8, 2026
Financings
Public offering of common stock or pre-funded warrants with accompanying common warrants
Oct 2, 2026
Closed: US$110M raised · US$2.9 a share · Warrants at US$3.5 · Leerink Partners +2
Dealers: Leerink Partners (co-lead), Guggenheim Securities (co-lead), Wells Fargo Securities (co-lead)
Buyers: OrbiMed; GordonMD Global Investments; BVF Partners; Coastlands Capital; RTW Investments
Use of proceeds: Advance lead program MICVO through key clinical milestones including planned Phase 3 Headliner trial, plus working capital and general corporate purposes
Announced Sep 29, 2026 · Update Sep 30, 2026 · Closed Oct 2, 2026
Private placement of securities with accompanying warrants
Aug 13, 2026
Closed: US$50M raised
Use of proceeds: Advance MICVO through key clinical milestones and continue patient follow-up so data can mature
Decks
Corporate Update (September 2026)
Corporate update · 33 slides · Sep 9, 2026
Investor Presentation (March 2026)
Investor deck · 43 slides · Mar 23, 2026
Corporate Update (December 2025)
Corporate update · 29 slides · Dec 18, 2025
Investor Presentation (November 2025)
Investor deck · 31 slides · Nov 3, 2025
Pyxis Oncology, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 81 in all · newest Oct 28, 2026 · oldest 2021
- Decks
- 13 decks · latest Sep 9, 2026
Where Pyxis Oncology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PYXS · Home listing | NASDAQ | United States | USD |
| BOATS:PYXS · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Pyxis Oncology, Inc.